FindTrial
Sign In

Drugs prescribed, medication adherence and quality of life among patients with open angle glaucoma

Pharmacotherapy, medication adherence and quality of life among patients with open angle glaucoma in a tertiary care hospital-A prospective observational study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/10/046445
Enrollment
101
Registered
2022-10-13
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H401- Open-angle glaucoma

Interventions

None listed

Sponsors

Sharon Rogers
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - Consenting adult patients ( >18 years) with an ophthalmologist confirmed diagnosis of open angle glaucoma - Patients receiving one or more glaucoma medications

Exclusion criteria

Exclusion criteria: - Patients who are critically ill - Patients with mental illness (schizophrenia, psychosis) - Patients who refuse follow up

Design outcomes

Primary

MeasureTime frame
To assess adherence to pharmacotherapy of glaucoma using MARS -5 scaleTimepoint: over 3 months—

Secondary

MeasureTime frame
To determine the factors leading to nonadherenceTimepoint: while on medications;To determine the quality of life in the patients at baseline and using EQ5D5L scaleTimepoint: At 3 months—

Countries

India

Contacts

Public ContactSharon Rogers

St.Johns Medical College

mangalarao75@hotmail.com9980741639

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026